Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
34
ORKA Quote, Financials, Valuation and Earnings
Last price:
$20.17
Seasonality move
:
--
Day range:
$19.84 - $21.58
52-week range:
$18.20 - $31.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.09x
Volume:
2.5M
Avg. volume:
332.8K
1-year change:
--
Market cap:
$710.1M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for ORKA
Dec 31
2024
Most recent earnings per share
-$1.46
Missed by $1.14
(Sep 30/2024)
Consensus Estimate
-$0.32
(Sep 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ORKA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | -- | -- | -- | -$0.98 | -- |
| 09/30/2024 | Q3 | -- | -- | -$1.46 | -$0.32 | -$1.14 |
| 06/30/2024 | Q2 | -- | -- | -$0.76 | -- | -- |
Oruka Therapeutics Earnings Questions
-
How Much did Oruka Therapeutics Generate in Revenue Last Quarter?
Oruka Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Oruka Therapeutics Beat Earnings Last Quarter?
Oruka Therapeutics announced earnings per share of -$1.46 which represents a miss of analyst forecast a -$0.32 per share.
-
Is Oruka Therapeutics Profitable?
Oruka Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Oruka Therapeutics EPS Next Year?
Oruka Therapeutics's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is Oruka Therapeutics's Earnings Date?
Oruka Therapeutics's next earnings date is December 31, 2024.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
